Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure
- Conditions
- the Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in Liver
- Registration Number
- NCT01312220
- Lead Sponsor
- National Taiwan University Hospital
- Brief Summary
To study the correlation of serological growth factors and the hepatic progenitor cells involved in liver regeneration of liver failure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Acute liver failure Received iver transplantation
Exclusion Criteria
Pregnancy Sepsis Heart failure
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link serum growth factors to hepatic progenitor cell regeneration in NCT01312220?
How do serum growth factor levels in NCT01312220 compare with standard-of-care outcomes in acute liver failure patients?
Which serological biomarkers from NCT01312220 predict hepatic progenitor cell response in acute liver failure (ALF)?
Are elevated growth factors in NCT01312220 associated with adverse events like hepatic encephalopathy in ALF patients?
What combination therapies with growth factors enhance liver regeneration in ALF models beyond NCT01312220 findings?
Trial Locations
- Locations (1)
NTUH
🇨🇳Taipei, Taiwan